Document is current
Any future updates will be listed below
-
Authors
Di Luca, Daniel Garbin https://orcid.org/0000-0002-1356-4919
Reyes, Nikolai Gil D. https://orcid.org/0000-0001-8762-6556
Fox, Susan H.
- License Information
-
More Information
Article History
Accepted: 26 June 2022
First Online: 16 July 2022
Declarations
:
: The authors declare that no funding supported this manuscript preparation or submission.
: The authors declare that there are no other conflicts of interest relevant to this work. Dr. Susan Fox declares Consulting or Advisory Board Membership with honoraria: Alexion; Bial, Pharma 2B; Sunovion; Paladin; grant funding from Michael J Fox Foundation for Parkinson Research, NIH; Parkinson Canada, and site PI for Clinical Trials for Alexion, Biotie, Eisai, Pharma2B, Revance; She also received clinic support from the Edmond J Safra Foundation for Parkinson Research; Parkinson Foundation and the UHN Foundation, honoraria from the International Parkinson and Movement Disorder Society and royalties from Oxford University Press.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: (1) Research project: A. Conception, B. Organization; (2) Manuscript preparation: A. Literature search and data analysis, B. Writing of the first draft, C. Review, and critique. DDL: 1A, 1B, 2A, 2B. NR: 1A, 1B, 2A, 2B. SHF: 1A, 1B, 2C.
